Authors
Latest:
Utility of the PhaSeal Closed System Drug Transfer DeviceThe Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Latest:
Maximizing Electronic Medical Records: The Electronic Medical Record Adoption Model and the Health-System PharmacistThere is growing confidence that health information technology investments will begin to meet expectations.
Latest:
Impact of Initial Days' Supply of Angiotensin II Receptor BlockersFor ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Latest:
Examining Part D Beneficiaries' Medication Use in the Doughnut HoleThe authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.
Latest:
Challenges and Opportunities with Oral Oncology AgentsPharmacists can collaborate with oncologists to maximize patient outcomes through appropriate dispensing, side-effect monitoring, and adherence.
Latest:
Real-World Dosing and Utilization of Ustekinumab Among Patients With PsoriasisThis study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Latest:
Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient SafetyCollaboration Is a necessary component of successful compliance with USP , and technology can help.
Latest:
Pomalidomide Labeled an Advance in Multiple MyelomaThe combination of pomalidomide and a steroid significantly improved outcomes for patients with multiple myeloma who have exhausted other novel therapies, marking what researchers say is a notable advancement for a sizable proportion of those treated for the disease.
Latest:
Lifestyle Modifications for Patients with Metabolic SyndromePharmacists are in a unique position to inform patients about the various features and proper use of blood pressure monitors.
Latest:
Going Above and Beyond as PharmacistsLearn more about what it's like to work for a Walgreens specialty pharmacy.
Latest:
Bullied into ExtinctionGovernment involvement may be required in order to keep corporate entities from bullying specialty pharmacies out of business.
Latest:
FDA OKs Biosimilar Adalimumab for Autoimmune ConditionsThe FDA has approved Sandoz’s biosimilar adalimumab, Hyrimoz (adalimumab-adaz) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.
Latest:
Are PBMs the Big Bad Wolf?Pharmacy benefit managers are a large part of our health care benefits, but do they bring value?
Latest:
Pain Management in End-Stage Renal DiseaseRecently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD).
Latest:
Liraglutide (Victoza): A Quick Guide for PharmacistsWhat role does this medication play in diabetes therapy, and what are its clinical benefits, compared with competitors?
Latest:
What Are Treatment Approaches to Liver Cancer?How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.
Latest:
Adherence With Lipid-Lowering, Antihypertensive, and Diabetes MedicationsAdherence was examined among patients taking medications, individually and in combinations, to treat hypertension, hyperlipidemia, and/or diabetes.
Latest:
Hypertension Treatment Guidelines UpdateHealth care providers often encounter patients with high blood pressure, especially systolic, who come and go without proper treatment and eventually end up in the hospital with a heart attack, kidney failure, or a stroke.
Latest:
Educational Pharmacogenetics Resources for PharmacistsThe utility of pharmacogenetic testing has exponentially increased within the past few years.
Latest:
Impact of Initial Days' Supply of Angiotensin II Receptor BlockersFor ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Latest:
Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science LiaisonAs medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers
